Multifactor Channel Investing for Tomorrow, Today: Exploring the Future of Health Care By Max ChenApril 28, 2019
Innovative ETFs Channel Healthcare, Biotech ETFs Plunge on Mounting Political Pressures By Max ChenApril 18, 2019
Innovative ETFs Channel Healthcare ETFs Lag the Broader Market Amidst Regulation Scare By Max ChenApril 15, 2019
Relative Value Channel Will Tighter Government Regulation Test Health Care ETFs? By Ben HernandezApril 15, 2019
Innovative ETFs Channel Healthcare ETFs Deteriorate on Congress’ Threats to Drug Prices By Max ChenApril 12, 2019
Leveraged & Inverse Channel Health Care ETFs Get a Boost From Latest Jobs Report By Ben HernandezApril 6, 2019
Relative Value Channel Warren Buffett on Overhauling Health Care: “There’s Enormous Resistance to Change” By Ben HernandezMarch 18, 2019
Innovative ETFs Channel Healthcare, Biotech ETFs XLV and XBI Slide on FDA’s Uncertain Outlook By Max ChenMarch 6, 2019
Innovative ETFs Channel A Specialty Biotech ETF Strengthens on Optimism Over CRISPR Advancements By Max ChenMarch 1, 2019
Innovative ETFs Channel Pharmaceutical ETFs Break Out on Horizon Pharma’s Positive Drug Results By Max ChenFebruary 28, 2019
Innovative ETFs Channel Specialized Biotech ETF Rallies on MacroGenics Positive Trial Results By Max ChenFebruary 6, 2019
Core Equity Channel Healthcare ETFs Slip After Abbot Lab’s Revenue Miss, Weak Outlook By Max ChenJanuary 23, 2019
Leveraged & Inverse Channel Rising U.S. Health Care Spending a Boon to this Leveraged ETF By Ben HernandezJanuary 8, 2019